M. C. Mir

Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy

I. Derweesh, R. Campi, E. Roussel, 2024, European urology open science.

Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review and a Network Meta-analysis.

L. Albiges, M. Marchioni, Giorgio Gandaglia, 2024, European urology oncology.